Search Within

Aaron Philip Mitchell

Formats
  1. Journal Article (29)
  2. Meeting Abstract (21)
  3. Editorial (4)
  4. Correspondence (2)
  5. Research Letter (2)
  6. Review (2)
Groups
  1. Department of Medicine (60)
  2. Epidemiology and Biostatistics (60)
  3. Genitourinary Oncology Service (60)
  4. Health Outcomes Research Group (60)
  5. Population Sciences Research Program (60)
  6. Solid Tumor Oncology Division (60)

More Groups

People
  1. Peter Bach (16)
  2. Akriti Mishra (12)
  3. Sonia Persaud (10)
  4. Michael Morris (7)
  5. Nirjhar Chakraborty (6)
  6. Niti Trivedi (6)

More People

Years
  1. 2025 (2)
  2. 2024 (20)
  3. 2023 (10)
  4. 2022 (10)
  5. 2021 (9)
  6. 2020 (7)

More Years

Publications
  1. Journal of Clinical Oncology (19)
  2. Journal of the National Comprehensive Cancer Network (5)
  3. The Oncologist (5)
  4. Annals of Oncology (2)
  5. BMJ: British Medical Journal (International Edition) (2)
  6. JAMA Network Open (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (21)
  2. Oxford University Press (11)
  3. Harborside Press (5)
  4. American Medical Association (4)
  5. BMJ Publishing Group Ltd. (4)
  6. Elsevier Inc. (3)

More Publishers

Results (60)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Trends in prices of checkpoint inhibitors in the US, 2016-2023
    Meeting Abstract

    Paul, J.; Mitchell, A. P.; Kesselheim, A. S.; Rome, B. N.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Overlapping and non-overlapping indications for checkpoint inhibitors in the US
    Meeting Abstract

    Paul, J.; Mitchell, A. P.; Kesselheim, A. S.; Rome, B. N.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Trends in pharmaceutical industry payments to US cancer centers, 2014-2021
    Meeting Abstract

    Mitchell, A. P.; Chakraborty, N.; Brown, M.; Persaud, S.; Gallagher, G. B.; Trivedi, N. U.; Bach, P. B.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Industry payments to physicians endorsing drugs and devices on a social media platform
    Research Letter

    Persaud, S.; Al Hadidi, S.; Anderson, T. S.; Gallagher, G.; Chimonas, S.; Korenstein, D.; Mitchell, A. P.
    JAMA - Journal of the American Medical Association (2024)

    Fulltext@MSK | Save
  • Commercial versus medicaid insurance and use of high-priced anticancer treatments
    Journal Article

    Mitchell, A. P.; Kinlaw, A. C.; Peacock-Hinton, S.; Dusetzina, S. B.; Winn, A. N.; Sanoff, H. K.; Lund, J. L.
    The Oncologist (2024)

    Fulltext@MSK | Save
  • Trends in financial payments from industry to US cancer centers, 2014-2021
    Journal Article

    Chakraborty, N.; Brown, M.; Persaud, S.; Gallagher, G.; Trivedi, N. U.; Bach, P. B.; Mitchell, A. P.
    JNCI Cancer Spectrum (2024)

    Fulltext@MSK | Save
  • Health care lobbying and oncology
    Journal Article

    Choradia, N.; Mitchell, A.; Nipp, R.
    Journal of the National Comprehensive Cancer Network (2024)

    Fulltext@MSK | Save
  • Premarket evidence and postmarketing requirements for real-time oncology review indication approvals
    Research Letter

    Mooghali, M.; Mohammad, A.; Wallach, J. D.; Mitchell, A. P.; Ross, J. S.; Ramachandran, R.
    JAMA Network Open (2024)

    Fulltext@MSK | Save
  • Characterization of accelerated approval status, trial endpoints and results, and recommendations in guidelines for oncology drug treatments from the National Comprehensive Cancer Network: Cross sectional study
    Journal Article

    Mooghali, M.; Mitchell, A. P.; Skydel, J. J.; Ross, J. S.; Wallach, J. D.; Ramachandran, R.
    BMJ Medicine (2024)

    Fulltext@MSK | Save
  • Costs to Medicare of nonrecommended bone-modifying agent use for castration-sensitive prostate cancer
    Journal Article

    Mitchell, A. P.; Nemirovsky, D.; Mishra Meza, A.; Chakraborty, N.; Persaud, S.; Farooki, A.; Morris, M. J.
    JCO Oncology Practice (2024)

    Fulltext@MSK | Save